Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
AbCellera Biologics Inc
ABCL | US
3.99
USD0.08
2.05%
ABCL | US
About AbCellera Biologics Inc
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
21/04/2026
Close
3.99
Open
3.92
High
3.99
Low
3.83
AbCellera Biologics Inc. builds an engine for antibody drug discovery and development. Its engine discovers antibodies from natural immune responses which are pre-enriched for antibodies. The company had discovery programs that are either completed in progress or under contract with partners. It has a research collaboration and license agreement with Eli Lilly and Company; and a research collaboration with Confo Therapeutics for the discovery of therapeutic antibody candidates targeting two undisclosed GPCR targets. The company was incorporated in 2012 and is headquartered in Vancouver Canada.
View LessABCL | US
Risk
43.3
Sharpe
0.80
Luna's Score
55/100
Recommendation
Hold
Luna says (ABCL | US)
What's Working
Strength based on increasing price with high volume
Low Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
What's not Working
High 6-Month Volatility (>65%)
Smallcap (300M - 2B USD)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
10 days
40.4%1 month
43.3%3 months
71.8%6 months
69.0%Returns
Fundamental Ratios
PE
-
Fwd. PE
27.47
Price to book
0.71
Debt to equity
0.06
Debt to assets
0.05
Ent. to EBITDA
5.30
Ent. to rev.
5.79
PEG
-
Other Fundamentals
EBITDA
-214.66M
MarketCap
1.12B
MarketCap(USD)
1.12B
Div. yield
-
Op. margin
-1.28K
Erngs. growth
45.90
Rev. growth
-27.20
Ret. on equity
-13.30
Short ratio
7.58
Short perc.
7.52
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Range10D
0.83
Range1M
0.83
Range3M
2.10
Volumes: Market Activity
Rel. volume
1.32
Price X volume
15.31M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 5.30 | - | Expensive |
| Ent. to Revenue | 5.79 | - | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 0.71 | 15.55 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 71.81 | - | Par |
| Debt to Equity | 0.06 | -1.23 | Expensive |
| Debt to Assets | 0.05 | 0.25 | Cheaper |
| Market Cap | 1.12B | - | Emerging |
